SCINAI IMMUNOTHERAPEUTICS LTD. Basic Shares Outstanding (Weighted Average)
SCINAI IMMUNOTHERAPEUTICS LTD. (SCNI) reported Basic Shares Outstanding (Weighted Average) of 9.34 billion shares for the 12-month period ending 2025-12-31, per its 20-F filed 2026-04-01.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfSharesOutstandingBasic · last filed 2026-04-01
- SCINAI IMMUNOTHERAPEUTICS LTD. weighted average number of shares outstanding, basic for the quarter ending 2023-06-30 was 1.35B shares, a 81.00% increase year-over-year.
- SCINAI IMMUNOTHERAPEUTICS LTD. weighted average number of shares outstanding, basic for the quarter ending 2023-03-31 was 1.30B shares, a 73.93% increase year-over-year.
- SCINAI IMMUNOTHERAPEUTICS LTD. weighted average number of shares outstanding, basic for the quarter ending 2022-06-30 was 746.90M shares.
- SCINAI IMMUNOTHERAPEUTICS LTD. weighted average number of shares outstanding, basic for the quarter ending 2022-03-31 was 744.71M shares.
| Period end | Weighted Average Number of Shares Outstanding, Basic 3 month | Weighted Average Number of Shares Outstanding, Basic 6 month | Weighted Average Number of Shares Outstanding, Basic 12 month |
|---|---|---|---|
| 2025-12-31 | 9.34B shares 20-F · filed 2026-04-01 | ||
| 2025-06-30 | 6.36B shares 6-K · filed 2025-09-02 | ||
| 2024-12-31 | 3.23B shares 20-F · filed 2026-04-01 | ||
| 2024-06-30 | 2.29B shares 6-K · filed 2025-09-02 | ||
| 2023-12-31 | 1.56B shares 20-F · filed 2026-04-01 | ||
| 2023-06-30 | 1.35B shares 6-K/A · filed 2023-08-18 | 1.32B shares 6-K · filed 2024-09-09 | |
| 2023-03-31 | 1.30B shares 10-Q · filed 2023-05-15 | ||
| 2022-12-31 | 754.08M shares 20-F · filed 2025-05-07 | ||
| 2022-06-30 | 746.90M shares 6-K/A · filed 2023-08-18 | 745.82M shares 6-K/A · filed 2023-08-18 | |
| 2022-03-31 | 744.71M shares 10-Q · filed 2023-05-15 | ||
| 2021-12-31 | 564.58M shares 20-F · filed 2024-05-15 |